Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$400M |
| 2 |
Citigroup
C
|
+$395M |
| 3 |
CELG
Celgene Corp
CELG
|
+$360M |
| 4 |
Amazon
AMZN
|
+$347M |
| 5 |
RTX Corp
RTX
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$397M |
| 2 |
Salesforce
CRM
|
+$355M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$354M |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$349M |
| 5 |
Autodesk
ADSK
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.61% |
| 2 | Financials | 4.93% |
| 3 | Healthcare | 4% |
| 4 | Consumer Discretionary | 3.82% |
| 5 | Industrials | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Virtu Financial
VIRT
$5.1B
| $20.3M | 0.01% |
930,636
+640,972
| +221% | +$15.1M |
|
1327
Group 1 Automotive
GPI
$3.11B
| $20.2M | 0.01% |
246,504
-32,421
| -12% | -$2.44M |
|
1328
Essential Properties Realty Trust
EPRT
$6.74B
| $20.2M | 0.01% |
1,007,261
-1,108,512
| -52% | -$22.6M |
|
1329
Digital Realty Trust
DLR
$73.9B
| $20.2M | 0.01% |
171,244
+159,605
| +1,371% | +$19M |
|
|
MDCO
1330
DELISTED
Medicines Co
MDCO
| $20.2M | 0.01% |
552,670
+166,559
| +43% | +$5.44M |
|
1331
PUT
Boston Scientific
BSX
$76B
| $20.1M | 0.01% |
468,600
+148,100
| +46% | +$5.7M |
|
1332
CALL
O'Reilly Automotive
ORLY
$74.3B
| $20.1M | 0.01% |
817,500
+22,500
| +3% | +$570K |
|
1333
Amdocs
DOX
$6.2B
| $20.1M | 0.01% |
324,034
+127,900
| +65% | +$7.39M |
|
|
JHG
1334
DELISTED
Janus Henderson
JHG
| $20.1M | 0.01% |
939,834
+916,942
| +4,006% | +$20.9M |
|
|
BHVN
1335
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $20.1M | 0.01% |
458,900
+388,500
| +552% | +$21.9M |
|
1336
Cameco
CCJ
$42.7B
| $20.1M | 0.01% |
1,869,396
+810,605
| +77% | +$8.73M |
|
1337
EPR Properties
EPR
$4.74B
| $20M | 0.01% |
268,691
+14,023
| +6% | +$1.09M |
|
1338
CALL
Ciena
CIEN
$60.9B
| $20M | 0.01% |
487,000
+41,400
| +9% | +$1.59M |
|
1339
Krystal Biotech
KRYS
$9.68B
| $20M | 0.01% |
497,170
+174,296
| +54% | +$5.7M |
|
|
CNR
1340
Core Natural Resources Inc
CNR
$4.75B
| $20M | 0.01% |
751,892
-140,763
| -16% | -$4.21M |
|
1341
Oracle
ORCL
$441B
| $20M | 0.01% |
350,195
+187,250
| +115% | +$10.1M |
|
1342
CALL
Equinix
EQIX
$108B
| $19.9M | 0.01% |
39,500
-38,000
| -49% | -$18.2M |
|
1343
Cummins
CMI
$87.4B
| $19.9M | 0.01% |
116,241
-44,989
| -28% | -$7.37M |
|
|
CLVS
1344
DELISTED
Clovis Oncology, Inc.
CLVS
| $19.9M | 0.01% |
1,337,160
+662,090
| +98% | +$12M |
|
1345
PENN Entertainment
PENN
$2.52B
| $19.9M | 0.01% |
1,031,467
+884,540
| +602% | +$17.9M |
|
1346
Arch Capital
ACGL
$33.7B
| $19.8M | 0.01% |
534,468
+59,801
| +13% | +$2.04M |
|
1347
Kosmos Energy
KOS
$1.52B
| $19.7M | 0.01% |
3,148,341
+1,015,296
| +48% | +$6.48M |
|
1348
PUT
HSBC
HSBC
$357B
| $19.7M | 0.01% |
471,900
-356,648
| -43% | -$14.9M |
|
1349
COPT Defense Properties
CDP
$4.23B
| $19.7M | 0.01% |
746,285
+343,115
| +85% | +$9.57M |
|
1350
Abercrombie & Fitch
ANF
$4.8B
| $19.7M | 0.01% |
1,226,629
+392,631
| +47% | +$9.08M |
|
Similar funds
Ken Griffin's Q2 2019 Portfolio in Review
As of Q2 2019, Ken Griffin held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.
- Ken Griffin's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
- Ken Griffin added most to Netflix in Q2 2019, an estimated $400M increase.
- Ken Griffin's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
- Ken Griffin fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
- Ken Griffin's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
- Ken Griffin opened 1,217 new positions and closed 1,335 in Q2 2019.
- Ken Griffin's portfolio value rose 8.5% quarter-over-quarter to $218B.
Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.